Expert evaluation on adverse effects of the Pfizer-COVID-19 vaccination
May 9, 2021

08V2021 version 3

https://www.americasfrontlinedoctors.org/frontline-news/expert-evaluation-on-adverse-effects-of-the-pfizer-covid-19-vaccination

Expert evaluation on adverse effects of the Pfizer-COVID-19 vaccination

Institute of Microstructure Technology, Karlsruhe Institute of Technology (KIT)

Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany;
podarcissicula@gmail.com

I, Hervé Seligmann, am writing this evaluation at the request of several people all over the world, for submission to any Court worldwide. I am a biomedical researcher of Israeli and Luxemburgish nationality, with over 100 peer-reviewed international publications. My proven record includes detecting in widely known and publicized data phenomena that escaped previous examinations. This includes the descriptions of two previously unknown types of RNA transcriptions, and of unsuspected structures in the genetic code that link gene and protein structures. I worked 5 years with Professor Didier Raoult at the Institut Hospitalo-Universitaire in Marseille, a first rank microbiology institute in the study of infectious diseases.

I am an independent researcher with no conflicts of interest. This evaluation summarizes several articles written with Haim Yativ and published on the nakim.org website and presented in our petition to the Israel Supreme Court.

Overview

Any medical treatment must be evaluated along a cost-benefit analysis. No treatment is risk free. It is in this respect that transparent availability of risk-group-stratified data on potential effects of vaccination, as compared to corresponding unvaccinated groups, must be available. These should be analysed by specialists free of any suspicions of conflicts of interests. The publication and unbiased discussion of their results must be facilitated, not hindered. Below I describe several potential negative vaccine effects, including vaccination-associated, documented 3- and 20-fold increases in infection and death rates, respectively. These cast serious doubts on positive outcomes of the above-mentioned cost-benefit analysis, which seems absent from public discourse. Further analyses show for ages 20-90 that increases in vaccination-associated mortality are inversely proportional to age, up to 60 % for those aged 20-24. Extrapolating these results for ages below 20 expects mortality increases beyond 100 % for those younger than 5.

It is essential to account for adverse vaccine effects during the period of vaccination. Most publications on COVID19-vaccination in Israel only refer to the period after full vaccination. This is misleading and tantamount to only tell cancer patients their survival rates after they survived a successful treatment. Standard estimations of treatment success include risks during the treatment, which is often a period of increased risks, as suggested below.

Below we detail a cost-benefit analysis focused on vaccine-associated COVID19 deaths, but not accounting for non-COVID19-associated, vaccination-associated deaths of two datasets released by the Israel Ministry of Health on February 11 in Ynet and on March 11 on correctiv.org. These reanalyses show that deaths occurring during the 5-week vaccination period and the first weeks after full vaccination, would require full vaccine protection against COVID19 over a postvaccination period of about 674.31 days (1.85 years or 22.2 months) for the Ynet data and 829.83 days (2.27 years or 27.3 months) for the correctiv.org data to compensate for the excess in COVID19 deaths occurring during and just after to the vaccination process. This assumes full vaccine protection, which is unrealistic, and does not account for adverse effects unrelated to COVID19. Accounting for these would lengthen the compensatory period required to reach a net cost-benefit balance of zero additional deaths due to vaccination.

Hence, one can estimate that in order for this vaccine to bear actual life-saving benefits, effective protection should last at least 2.5 (Ynet data from February 11) or 3 (correctiv.org data from March 11) years. The differences between datasets are because sample sizes are much larger and data on vaccine effects span a longer time period after full vaccination in the latter than in the former. Hence, the longer, least optimistic estimate is the most likely. This is why vaccination cost-benefit analyses favour vaccination only against organisms with stable genomes, meaning with low mutation rates. RNA genomes are the most mutable ones known.

A priori, the Israeli RNA-based vaccination has several potential risks. Vaccination works as a prophylactic. Vaccination of individuals while they are exposed to a pandemic has several adverse consequences.

1. Vaccination processes usually imply temporary immune system weakening, before vaccine-induced immunity is acquired. Hence, the vaccinated are fragilized during the vaccination process, and more likely to develop any diseases against which the immune system usually defends the body. This includes any viral and bacterial infections, and individual cancer cells that would escape extermination by the immune system during this vaccination-induced weakened period. This could cause cancer in the medium- or long-term.

2. In the long-term, the antibodies induced by the RNA vaccine will cause autoimmune reactions to the cells producing the viral protein encoded by the vaccine RNA, and to cells with natural human proteins resembling the viral protein encoded by the vaccine RNA.

3. Massive vaccination might select vaccine-resistant viral variants with likely catastrophic effects, especially on the vaccinated.

4. RNA from the vaccine will in some cases integrate chromosomes of the vaccinated, with potentially harmful consequences difficult to evaluate at this point. Any claim to the contrary is misleading and misinformed. Human chromosomes integrated genomes of retroviruses that include RNA->DNA reverse transcriptase genes. This was the topic of the 1976 Nobel prize in Physiology and could not be ignored by competent professionals. Reanalyses of two separate bodies of data, one published by the Israel Ministry of Health (Table 1) and one by the team of Dan Balicer from Clalit (our reanalyses of data from Dagan et al 2021), indicate adverse effects due to the 5-week vaccination process, as compared to the unvaccinated. Eight among ten authors of Dagan et al disclose receiving funds for other projects from Pfizer. Pfizer is also a main funder of the Israeli Ministry of Health. Hence, these are not unbiased, neutral and independent bodies, which is required for any study, and especially studies with such crucial consequences.


Preliminary cost-benefice evaluation of COVID19 vaccination



-- excerpt, rest at link above --

That point #3 is the big one, and one that I fear we are beginning to see now.